ATE346084T1 - Zwischenprodukte und verfahren zur herstellung von heptapeptid-oxytocinanaloga - Google Patents

Zwischenprodukte und verfahren zur herstellung von heptapeptid-oxytocinanaloga

Info

Publication number: ATE346084T1
Authority: AT; Austria
Prior art keywords: analogs; heptapeptide; oxytocine; producing; intermediate products
Prior art date: 2002-02-27

Application number

AT03743130T

Other languages

English (en)

Inventor

Kazimerz Wisniewski

Jacek Stalewski

Guancheng Jiang

Original Assignee

Ferring Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-02-27

Filing date

2003-02-13

Publication date

2006-12-15

2003-02-13 Application filed by Ferring Bv filed Critical Ferring Bv

2006-12-15 Application granted granted Critical

2006-12-15 Publication of ATE346084T1 publication Critical patent/ATE346084T1/de

Links

XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical class C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 title abstract 4
239000013067 intermediate product Substances 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
230000002194 synthesizing effect Effects 0.000 abstract 4
239000000543 intermediate Substances 0.000 abstract 2
XNOPRXBHLZRZKH-UHFFFAOYSA-N Oxytocin Natural products N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 XNOPRXBHLZRZKH-UHFFFAOYSA-N 0.000 abstract 1
101800000989 Oxytocin Proteins 0.000 abstract 1
102100031951 Oxytocin-neurophysin 1 Human genes 0.000 abstract 1
150000001298 alcohols Chemical class 0.000 abstract 1
229960001723 oxytocin Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/16—Oxytocins; Vasopressins; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

AT03743130T 2002-02-27 2003-02-13 Zwischenprodukte und verfahren zur herstellung von heptapeptid-oxytocinanaloga ATE346084T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US36034502P	2002-02-27	2002-02-27

Publications (1)

Publication Number	Publication Date
ATE346084T1 true ATE346084T1 (de)	2006-12-15

Family

ID=27766223

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03743130T ATE346084T1 (de)	2002-02-27	2003-02-13	Zwischenprodukte und verfahren zur herstellung von heptapeptid-oxytocinanaloga

Country Status (10)

Country	Link
US (3)	US7091314B2 (de)
EP (1)	EP1480998B1 (de)
JP (1)	JP4615221B2 (de)
AT (1)	ATE346084T1 (de)
AU (1)	AU2003211011A1 (de)
DE (1)	DE60309847T2 (de)
DK (1)	DK1480998T3 (de)
ES (1)	ES2277640T3 (de)
PT (1)	PT1480998E (de)
WO (1)	WO2003072597A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HRP20140716T1 (hr)	2008-03-31	2014-08-29	Ferring B.V.	Analozi oksitocina
EP2306971B1 (de) *	2008-07-03	2015-02-25	University Of Virginia Patent Foundation	Einheitsdosis von apadenoson
TWI463990B (zh)	2009-09-21	2014-12-11	Ferring Bv	催產素受體促進劑
ES2716862T3 (es)	2014-12-22	2019-06-17	Ferring Bv	Terapia con antagonistas del receptor de oxitocina en la fase lútea para la implantación y embarazo en mujeres que se someten a tecnologías de reproducción asistida
EP3359557A1 (de)	2015-10-06	2018-08-15	Ferring B.V.	Neue verfahren zur herstellung von barusiban und dessen zwischenprodukten
LT3400217T (lt)	2016-01-04	2022-06-27	Merck Serono S.A.	Hidroksipropiltiazolidino karboksamido l-valinato darinys, jo druska ir jo kristalinė forma
WO2018015497A2 (en)	2016-07-21	2018-01-25	ObsEva S.A.	Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriage
AU2020340670A1 (en)	2019-09-03	2022-04-07	ObsEva S.A.	Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriage
WO2021160597A1 (en)	2020-02-10	2021-08-19	ObsEva S.A.	Biomarkers for oxytocin receptor antagonist therapy
WO2025082311A1 (zh) *	2023-10-16	2025-04-24	高雄医学大学	肽醇的固相简便合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU906340D0 (en) *	1986-10-13	1991-04-29	Sandoz Ag	Synthesis in solid phase for producing peptonic alcohols
SE9002384D0 (sv)	1990-07-09	1990-07-09	Ferring Ab	Derivat av baklobshormoner
JP3158507B2 (ja) *	1991-07-09	2001-04-23	チッソ株式会社	光学活性３−フェニル−３−ヒドロキシプロピオン酸エステルの製造方法
FR2680506B1 (fr) *	1991-08-19	1994-09-02	Rhone Poulenc Rorer Sa	Procede de preparation de derives de la beta-phenylisoserine et leur utilisation.
SE501678C2 (sv)	1993-07-13	1995-04-10	Ferring Bv	Peptid med oxytocinantagonistaktivitet samt farmaceutisk komposition innehållande nämnda peptid
US5856721A (en) *	1994-09-08	1999-01-05	Gordin; Myron K.	Discharge lamp with offset or tilted arc tube
US5858972A (en) *	1996-01-11	1999-01-12	La Jolla Cancer Research Foundation	Antithrombotic agents and methods of use
SE9604341D0 (sv) *	1996-11-26	1996-11-26	Ferring Bv	Hepta-peptide oxytocin analogue
US6114310A (en) *	1998-01-23	2000-09-05	Microcide Pharmaceuticals, Inc.	Efflux pump inhibitors
US6245746B1 (en) *	1998-01-23	2001-06-12	Microcide Pharmaceuticals, Inc.	Efflux pump inhibitors
US6204279B1 (en) *	1998-06-03	2001-03-20	Microcide Pharmaceuticals, Inc.	Peptidomimetic efflux pump inhibitors
ES2144357B1 (es) *	1998-01-29	2000-12-16	Lipotec Sa	Procedimiento para la obtencion del analogo de somatostatina octreotide.
GB0115515D0 (en)	2001-06-25	2001-08-15	Ferring Bv	Oxytocin agonisys

2003
- 2003-02-13 AU AU2003211011A patent/AU2003211011A1/en not_active Abandoned
- 2003-02-13 AT AT03743130T patent/ATE346084T1/de active
- 2003-02-13 PT PT03743130T patent/PT1480998E/pt unknown
- 2003-02-13 JP JP2003571303A patent/JP4615221B2/ja not_active Expired - Fee Related
- 2003-02-13 DE DE60309847T patent/DE60309847T2/de not_active Expired - Lifetime
- 2003-02-13 ES ES03743130T patent/ES2277640T3/es not_active Expired - Lifetime
- 2003-02-13 DK DK03743130T patent/DK1480998T3/da active
- 2003-02-13 EP EP03743130A patent/EP1480998B1/de not_active Expired - Lifetime
- 2003-02-13 WO PCT/US2003/004301 patent/WO2003072597A1/en not_active Ceased
2004
- 2004-07-08 US US10/888,704 patent/US7091314B2/en not_active Expired - Lifetime
2006
- 2006-07-14 US US11/457,743 patent/US7304181B2/en not_active Expired - Fee Related
2007
- 2007-10-30 US US11/929,494 patent/US7816489B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AU2003211011A1 (en)	2003-09-09
EP1480998B1 (de)	2006-11-22
EP1480998A1 (de)	2004-12-01
WO2003072597A1 (en)	2003-09-04
DE60309847D1 (de)	2007-01-04
US20080177035A1 (en)	2008-07-24
US7816489B2 (en)	2010-10-19
JP2005532996A (ja)	2005-11-04
JP4615221B2 (ja)	2011-01-19
DK1480998T3 (da)	2007-03-26
ES2277640T3 (es)	2007-07-16
US7304181B2 (en)	2007-12-04
PT1480998E (pt)	2007-02-28
US20040248776A1 (en)	2004-12-09
US20060247157A1 (en)	2006-11-02
EP1480998A4 (de)	2005-06-08
US7091314B2 (en)	2006-08-15
DE60309847T2 (de)	2007-10-18

Legal Events

Date

Code

Title

Description

2007-08-15

UEP

Publication of translation of european patent specification

Ref document number: 1480998

Country of ref document: EP

Publication	Publication Date	Title
DE602004031895D1 (de)	2011-04-28	Verfahren zur Herstellung von Dichlorpropanol
DE60323192D1 (de)	2008-10-09	Verfahren zur Herstellung von Hydroxyalkylstärkederivaten
ATE215062T1 (de)	2002-04-15	Verfahren zur herstellung von cyclohexen- carboxylatderivate
DE60217489D1 (de)	2007-02-22	Verfahren zur herstellung von vollfarbenen anzeigetafeln
DE602005009856D1 (de)	2008-10-30	Verfahren zur reinigung von fsh
ATE482966T1 (de)	2010-10-15	Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
DE602004020895D1 (de)	2009-06-10	Verfahren zur herstellung von kohlenstoffnanospulen
ATE486857T1 (de)	2010-11-15	Verfahren zur herstellung von telmisartan
ATE346084T1 (de)	2006-12-15	Zwischenprodukte und verfahren zur herstellung von heptapeptid-oxytocinanaloga
ATE410500T1 (de)	2008-10-15	Verfahren zur herstellung von gereinigten fettsäuren
ATE470657T1 (de)	2010-06-15	Verfahren zur herstellung von isocyanaten
ATE424892T1 (de)	2009-03-15	Verfahren zur herstellung von derivaten des 4a,5, 9,10,11,12-hexahydrobenzofuro ä3a,3,2üä 2 ü- benzazepins
ATE332905T1 (de)	2006-08-15	Verfahren zur herstellung von acylphosphinoxiden
DE60322356D1 (de)	2008-09-04	Verfahren zur herstellung von 2-aminoindanderivaten
DE60314113D1 (de)	2007-07-12	Verfahren zur herstellung von phenylorganosiliciumzwischenprodukten
ATE496038T1 (de)	2011-02-15	Verfahren zur herstellung von quetiapin
ATE386027T1 (de)	2008-03-15	Verfahren zur herstellung von valsartan
DE60301444D1 (de)	2005-10-06	Verfahren zur Herstellung von Polyalkylphenoxyaminoalkanen
ATE341558T1 (de)	2006-10-15	Verfahren zur herstellung von topiramate
ATE417826T1 (de)	2009-01-15	Verfahren zur herstellung von zwischenprodukten
DE60331302D1 (de)	2010-04-01	Verfahren zur herstellung von dichtungen
DE60330749D1 (de)	2010-02-11	Verfahren zur herstellung von 7-alpha-methylsteroide
DE602004031727D1 (de)	2011-04-21	Neues verfahren und zwischenprodukte zur herstellung von 19-nor-steroiden
DE60234943D1 (de)	2010-02-11	Verfahren zur herstellung von nitrierstahl
DE60324881D1 (de)	2009-01-08	Verfahren zur Herstellung von Polyalkylphenoxyaminoalkanen